The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2019 | Cardiotoxicity in hematology oncology: MPNs
Arjun Ghosh
• 15 Nov 2019
Arjun Ghosh, MBBS, MRCP(UK), MRCP(Cardiology), PhD, FHEA, FACC, Barts Health NHS Trust & University College London Hospitals NHS Foundation Trust, London, UK, gives an overview of the most common cardiotoxicities in hematology oncology, focusing on MPNs. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
